Neurocrine Biosciences, Inc. (OQ:NBIX)

Business Focus: Bio Therapeutic Drugs

Latest 10 SEC filings (by transaction date) for NBIX within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET August 25th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Aug 13/19 Aug 9/19 Gorman Kevin Charles Direct Ownership Incentive Stock Option M - Exercise or conversion exempt under rule 16b-3 -3,031 $32.99
Aug 13/19 Aug 9/19 Gorman Kevin Charles Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 3,031 $32.99
Aug 8/19 Aug 8/19 Gorman Kevin Charles Direct Ownership Non-Qualified Stock Option M - Exercise or conversion exempt under rule 16b-3 -26,330 $8.66
Aug 8/19 Aug 8/19 Gorman Kevin Charles Direct Ownership Common Stock S - Open market or private sale -26,330 $95.64
Aug 8/19 Aug 8/19 Gorman Kevin Charles Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 26,330 $8.66
Aug 8/19 Aug 7/19 Gorman Kevin Charles Direct Ownership Non-Qualified Stock Option M - Exercise or conversion exempt under rule 16b-3 -2,759 $8.66
Aug 8/19 Aug 7/19 Gorman Kevin Charles Direct Ownership Common Stock S - Open market or private sale -2,759 $95.12
Aug 8/19 Aug 7/19 Gorman Kevin Charles Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 2,759 $8.66
Aug 8/19 Aug 6/19 Gorman Kevin Charles Direct Ownership Non-Qualified Stock Option M - Exercise or conversion exempt under rule 16b-3 -50,911 $8.66
Aug 8/19 Aug 6/19 Gorman Kevin Charles Direct Ownership Common Stock S - Open market or private sale -50,911 $95.15
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for NBIX within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET August 25th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Aug 13/19 Aug 9/19 Gorman Kevin Charles Direct Ownership Incentive Stock Option M - Exercise or conversion exempt under rule 16b-3 -3,031 $32.99
Aug 13/19 Aug 9/19 Gorman Kevin Charles Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 3,031 $32.99
Aug 8/19 Aug 8/19 Gorman Kevin Charles Direct Ownership Non-Qualified Stock Option M - Exercise or conversion exempt under rule 16b-3 -26,330 $8.66
Aug 8/19 Aug 7/19 Gorman Kevin Charles Direct Ownership Non-Qualified Stock Option M - Exercise or conversion exempt under rule 16b-3 -2,759 $8.66
Aug 8/19 Aug 6/19 Gorman Kevin Charles Direct Ownership Non-Qualified Stock Option M - Exercise or conversion exempt under rule 16b-3 -50,911 $8.66
Aug 8/19 Aug 8/19 Gorman Kevin Charles Direct Ownership Common Stock S - Open market or private sale -26,330 $95.64
Aug 8/19 Aug 8/19 Gorman Kevin Charles Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 26,330 $8.66
Aug 8/19 Aug 7/19 Gorman Kevin Charles Direct Ownership Common Stock S - Open market or private sale -2,759 $95.12
Aug 8/19 Aug 7/19 Gorman Kevin Charles Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 2,759 $8.66
Aug 8/19 Aug 6/19 Gorman Kevin Charles Direct Ownership Common Stock S - Open market or private sale -50,911 $95.15
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now
Comment On!
140

Twitter

Search (past week) for $NBIX

StockTwits